Global Next-Generation Sequencing (NGS) Services Supply, Demand and Key Producers, 2026-2032

January 2026 | 128 pages | ID: GA4F1DE4FDCEN
GlobalInfoResearch

US$ 4,480.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The global Next-Generation Sequencing (NGS) Services market size is expected to reach $ 75300 million by 2032, rising at a market growth of 16.0% CAGR during the forecast period (2026-2032).

Next-Generation Sequencing (NGS) Services refer to comprehensive genetic analysis solutions based on high-throughput sequencing platforms, enabling the detection and analysis of genomic, transcriptomic, and epigenomic information at multiple levels. By leveraging parallelized, large-scale, and high-precision sequencing, NGS dramatically improves the efficiency and accuracy of genetic data acquisition, generating massive DNA or RNA sequence datasets in a single run. These services encompass the entire workflow, including sample preparation, library construction, sequencing operations, data processing, and bioinformatics analysis, while offering customized solutions for diverse needs such as research, clinical diagnostics, drug development, agricultural breeding, and microbiology studies. With advantages in cost efficiency, data depth, and application breadth, NGS services have become an essential infrastructure and innovation driver in precision medicine, life sciences, and the biotechnology industry.

The accelerated implementation of global precision medicine strategies and continuous advancements in bioinformatics are creating vast growth opportunities for the NGS services market. Increased government funding for genomics research and clinical translation projects such as early cancer screening is driving demand expansion among hospitals, research institutions, and biopharmaceutical companies. With significant reductions in sequencing costs and faster turnaround times, NGS has transitioned from exploratory research to large-scale clinical applications, covering areas such as tumor profiling, companion diagnostics, pathogen detection, and rare disease screening. Across the value chain, deeper collaborations between platform technology providers, service operators, and downstream application sectors are accelerating the adoption of new service models and value-added applications.

Despite rapid growth, the NGS services market faces challenges such as the lack of standardized data interpretation protocols, stringent regulatory requirements for clinical applications, and compliance risks related to data security. Regulatory differences across countries and regions increase the complexity of cross-border operations. High-quality bioinformatics analysis depends on experienced technical teams and robust computing infrastructure, creating barriers to entry. Certain niche segments demand extremely high sequencing accuracy and sensitivity, requiring continuous investment in R&D and quality control. Additionally, as market competition intensifies, balancing price pressures with differentiated service capabilities has become a critical test for business sustainability and expansion.

In the coming years, downstream demand for NGS services will diversify and integrate across multiple sectors. In healthcare, personalized treatment and early disease screening will continue to expand, particularly in the precision diagnosis of cancer, infectious diseases, and genetic disorders. In the biopharmaceutical industry, NGS will play a key role in new drug target discovery, elucidating drug response mechanisms, and stratifying patients in clinical trials. Agriculture and environmental sciences will further leverage NGS for crop improvement, animal breeding, and microbiome monitoring. Meanwhile, AI-driven automated analysis and cloud-based data collaboration will drive NGS services toward higher efficiency and broader accessibility, meeting the growing need for real-time, large-scale, multidimensional genetic information in both research and industrial applications.

This report studies the global Next-Generation Sequencing (NGS) Services demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Next-Generation Sequencing (NGS) Services, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Next-Generation Sequencing (NGS) Services that contribute to its increasing demand across many markets.

Highlights and key features of the study

Global Next-Generation Sequencing (NGS) Services total market, 2021-2032, (USD Million)

Global Next-Generation Sequencing (NGS) Services total market by region & country, CAGR, 2021-2032, (USD Million)

U.S. VS China: Next-Generation Sequencing (NGS) Services total market, key domestic companies, and share, (USD Million)

Global Next-Generation Sequencing (NGS) Services revenue by player, revenue and market share 2021-2026, (USD Million)

Global Next-Generation Sequencing (NGS) Services total market by Type, CAGR, 2021-2032, (USD Million)

Global Next-Generation Sequencing (NGS) Services total market by Application, CAGR, 2021-2032, (USD Million)

This report profiles major players in the global Next-Generation Sequencing (NGS) Services market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Eurofins Scientific, Natera, BGI, Illumina, Roche, LabCorp, Berry Genomics, Thermo Fisher Scientific, Macrogen, Oxford Nanopore, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Next-Generation Sequencing (NGS) Services market

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.

Global Next-Generation Sequencing (NGS) Services Market, By Region:
  • United States
  • China
  • Europe
  • Japan
  • South Korea
  • ASEAN
  • India
  • Rest of World
Global Next-Generation Sequencing (NGS) Services Market, Segmentation by Type:
  • Targeted Sequencing
  • Whole Exome Sequencing
  • Whole Genome Sequencing
Global Next-Generation Sequencing (NGS) Services Market, Segmentation by Application:
  • Hospitals and Clinics
  • Biopharma Companies
  • Academic & Research Organizations
  • Others
Companies Profiled:
  • Eurofins Scientific
  • Natera
  • BGI
  • Illumina
  • Roche
  • LabCorp
  • Berry Genomics
  • Thermo Fisher Scientific
  • Macrogen
  • Oxford Nanopore
  • Novogene
  • Pacific Biosciences
  • Azenta Life Sciences
Key Questions Answered
1. How big is the global Next-Generation Sequencing (NGS) Services market?
2. What is the demand of the global Next-Generation Sequencing (NGS) Services market?
3. What is the year over year growth of the global Next-Generation Sequencing (NGS) Services market?
4. What is the total value of the global Next-Generation Sequencing (NGS) Services market?
5. Who are the Major Players in the global Next-Generation Sequencing (NGS) Services market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY

1.1 Next-Generation Sequencing (NGS) Services Introduction
1.2 World Next-Generation Sequencing (NGS) Services Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Next-Generation Sequencing (NGS) Services Total Market by Region (by Headquarter Location)
  1.3.1 World Next-Generation Sequencing (NGS) Services Market Size by Region (2021-2032), (by Headquarter Location)
  1.3.2 United States Based Company Next-Generation Sequencing (NGS) Services Revenue (2021-2032)
  1.3.3 China Based Company Next-Generation Sequencing (NGS) Services Revenue (2021-2032)
  1.3.4 Europe Based Company Next-Generation Sequencing (NGS) Services Revenue (2021-2032)
  1.3.5 Japan Based Company Next-Generation Sequencing (NGS) Services Revenue (2021-2032)
  1.3.6 South Korea Based Company Next-Generation Sequencing (NGS) Services Revenue (2021-2032)
  1.3.7 ASEAN Based Company Next-Generation Sequencing (NGS) Services Revenue (2021-2032)
  1.3.8 India Based Company Next-Generation Sequencing (NGS) Services Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
  1.4.1 Next-Generation Sequencing (NGS) Services Market Drivers
  1.4.2 Factors Affecting Demand
  1.4.3 Major Market Trends

2 DEMAND SUMMARY

2.1 World Next-Generation Sequencing (NGS) Services Consumption Value (2021-2032)
2.2 World Next-Generation Sequencing (NGS) Services Consumption Value by Region
  2.2.1 World Next-Generation Sequencing (NGS) Services Consumption Value by Region (2021-2026)
  2.2.2 World Next-Generation Sequencing (NGS) Services Consumption Value Forecast by Region (2027-2032)
2.3 United States Next-Generation Sequencing (NGS) Services Consumption Value (2021-2032)
2.4 China Next-Generation Sequencing (NGS) Services Consumption Value (2021-2032)
2.5 Europe Next-Generation Sequencing (NGS) Services Consumption Value (2021-2032)
2.6 Japan Next-Generation Sequencing (NGS) Services Consumption Value (2021-2032)
2.7 South Korea Next-Generation Sequencing (NGS) Services Consumption Value (2021-2032)
2.8 ASEAN Next-Generation Sequencing (NGS) Services Consumption Value (2021-2032)
2.9 India Next-Generation Sequencing (NGS) Services Consumption Value (2021-2032)

3 WORLD NEXT-GENERATION SEQUENCING (NGS) SERVICES COMPANIES COMPETITIVE ANALYSIS

3.1 World Next-Generation Sequencing (NGS) Services Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
  3.2.1 Global Next-Generation Sequencing (NGS) Services Industry Rank of Major Players
  3.2.2 Global Concentration Ratios (CR4) for Next-Generation Sequencing (NGS) Services in 2025
  3.2.3 Global Concentration Ratios (CR8) for Next-Generation Sequencing (NGS) Services in 2025
3.3 Next-Generation Sequencing (NGS) Services Company Evaluation Quadrant
3.4 Next-Generation Sequencing (NGS) Services Market: Overall Company Footprint Analysis
  3.4.1 Next-Generation Sequencing (NGS) Services Market: Region Footprint
  3.4.2 Next-Generation Sequencing (NGS) Services Market: Company Product Type Footprint
  3.4.3 Next-Generation Sequencing (NGS) Services Market: Company Product Application Footprint
3.5 Competitive Environment
  3.5.1 Historical Structure of the Industry
  3.5.2 Barriers of Market Entry
  3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity

4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)

4.1 United States VS China: Next-Generation Sequencing (NGS) Services Revenue Comparison (by Headquarter Location)
  4.1.1 United States VS China: Next-Generation Sequencing (NGS) Services Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
  4.1.2 United States VS China: Next-Generation Sequencing (NGS) Services Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Next-Generation Sequencing (NGS) Services Consumption Value Comparison
  4.2.1 United States VS China: Next-Generation Sequencing (NGS) Services Consumption Value Comparison (2021 & 2025 & 2032)
  4.2.2 United States VS China: Next-Generation Sequencing (NGS) Services Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Next-Generation Sequencing (NGS) Services Companies and Market Share, 2021-2026
  4.3.1 United States Based Next-Generation Sequencing (NGS) Services Companies, Headquarters (States, Country)
  4.3.2 United States Based Companies Next-Generation Sequencing (NGS) Services Revenue, (2021-2026)
4.4 China Based Companies Next-Generation Sequencing (NGS) Services Revenue and Market Share, 2021-2026
  4.4.1 China Based Next-Generation Sequencing (NGS) Services Companies, Company Headquarters (Province, Country)
  4.4.2 China Based Companies Next-Generation Sequencing (NGS) Services Revenue, (2021-2026)
4.5 Rest of World Based Next-Generation Sequencing (NGS) Services Companies and Market Share, 2021-2026
  4.5.1 Rest of World Based Next-Generation Sequencing (NGS) Services Companies, Headquarters (Province, Country)
  4.5.2 Rest of World Based Companies Next-Generation Sequencing (NGS) Services Revenue (2021-2026)

5 MARKET ANALYSIS BY TYPE

5.1 World Next-Generation Sequencing (NGS) Services Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
  5.2.1 Targeted Sequencing
  5.2.2 Whole Exome Sequencing
  5.2.3 Whole Genome Sequencing
5.3 Market Segment by Type
  5.3.1 World Next-Generation Sequencing (NGS) Services Market Size by Type (2021-2026)
  5.3.2 World Next-Generation Sequencing (NGS) Services Market Size by Type (2027-2032)
  5.3.3 World Next-Generation Sequencing (NGS) Services Market Size Market Share by Type (2027-2032)

6 MARKET ANALYSIS BY APPLICATION

6.1 World Next-Generation Sequencing (NGS) Services Market Size Overview by Application: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Application
  6.2.1 Hospitals and Clinics
  6.2.2 Biopharma Companies
  6.2.3 Academic & Research Organizations
  6.2.4 Others
6.3 Market Segment by Application
  6.3.1 World Next-Generation Sequencing (NGS) Services Market Size by Application (2021-2026)
  6.3.2 World Next-Generation Sequencing (NGS) Services Market Size by Application (2027-2032)
  6.3.3 World Next-Generation Sequencing (NGS) Services Market Size Market Share by Application (2021-2032)

7 COMPANY PROFILES

7.1 Eurofins Scientific
  7.1.1 Eurofins Scientific Details
  7.1.2 Eurofins Scientific Major Business
  7.1.3 Eurofins Scientific Next-Generation Sequencing (NGS) Services Product and Services
  7.1.4 Eurofins Scientific Next-Generation Sequencing (NGS) Services Revenue, Gross Margin and Market Share (2021-2026)
  7.1.5 Eurofins Scientific Recent Developments/Updates
  7.1.6 Eurofins Scientific Competitive Strengths & Weaknesses
7.2 Natera
  7.2.1 Natera Details
  7.2.2 Natera Major Business
  7.2.3 Natera Next-Generation Sequencing (NGS) Services Product and Services
  7.2.4 Natera Next-Generation Sequencing (NGS) Services Revenue, Gross Margin and Market Share (2021-2026)
  7.2.5 Natera Recent Developments/Updates
  7.2.6 Natera Competitive Strengths & Weaknesses
7.3 BGI
  7.3.1 BGI Details
  7.3.2 BGI Major Business
  7.3.3 BGI Next-Generation Sequencing (NGS) Services Product and Services
  7.3.4 BGI Next-Generation Sequencing (NGS) Services Revenue, Gross Margin and Market Share (2021-2026)
  7.3.5 BGI Recent Developments/Updates
  7.3.6 BGI Competitive Strengths & Weaknesses
7.4 Illumina
  7.4.1 Illumina Details
  7.4.2 Illumina Major Business
  7.4.3 Illumina Next-Generation Sequencing (NGS) Services Product and Services
  7.4.4 Illumina Next-Generation Sequencing (NGS) Services Revenue, Gross Margin and Market Share (2021-2026)
  7.4.5 Illumina Recent Developments/Updates
  7.4.6 Illumina Competitive Strengths & Weaknesses
7.5 Roche
  7.5.1 Roche Details
  7.5.2 Roche Major Business
  7.5.3 Roche Next-Generation Sequencing (NGS) Services Product and Services
  7.5.4 Roche Next-Generation Sequencing (NGS) Services Revenue, Gross Margin and Market Share (2021-2026)
  7.5.5 Roche Recent Developments/Updates
  7.5.6 Roche Competitive Strengths & Weaknesses
7.6 LabCorp
  7.6.1 LabCorp Details
  7.6.2 LabCorp Major Business
  7.6.3 LabCorp Next-Generation Sequencing (NGS) Services Product and Services
  7.6.4 LabCorp Next-Generation Sequencing (NGS) Services Revenue, Gross Margin and Market Share (2021-2026)
  7.6.5 LabCorp Recent Developments/Updates
  7.6.6 LabCorp Competitive Strengths & Weaknesses
7.7 Berry Genomics
  7.7.1 Berry Genomics Details
  7.7.2 Berry Genomics Major Business
  7.7.3 Berry Genomics Next-Generation Sequencing (NGS) Services Product and Services
  7.7.4 Berry Genomics Next-Generation Sequencing (NGS) Services Revenue, Gross Margin and Market Share (2021-2026)
  7.7.5 Berry Genomics Recent Developments/Updates
  7.7.6 Berry Genomics Competitive Strengths & Weaknesses
7.8 Thermo Fisher Scientific
  7.8.1 Thermo Fisher Scientific Details
  7.8.2 Thermo Fisher Scientific Major Business
  7.8.3 Thermo Fisher Scientific Next-Generation Sequencing (NGS) Services Product and Services
  7.8.4 Thermo Fisher Scientific Next-Generation Sequencing (NGS) Services Revenue, Gross Margin and Market Share (2021-2026)
  7.8.5 Thermo Fisher Scientific Recent Developments/Updates
  7.8.6 Thermo Fisher Scientific Competitive Strengths & Weaknesses
7.9 Macrogen
  7.9.1 Macrogen Details
  7.9.2 Macrogen Major Business
  7.9.3 Macrogen Next-Generation Sequencing (NGS) Services Product and Services
  7.9.4 Macrogen Next-Generation Sequencing (NGS) Services Revenue, Gross Margin and Market Share (2021-2026)
  7.9.5 Macrogen Recent Developments/Updates
  7.9.6 Macrogen Competitive Strengths & Weaknesses
7.10 Oxford Nanopore
  7.10.1 Oxford Nanopore Details
  7.10.2 Oxford Nanopore Major Business
  7.10.3 Oxford Nanopore Next-Generation Sequencing (NGS) Services Product and Services
  7.10.4 Oxford Nanopore Next-Generation Sequencing (NGS) Services Revenue, Gross Margin and Market Share (2021-2026)
  7.10.5 Oxford Nanopore Recent Developments/Updates
  7.10.6 Oxford Nanopore Competitive Strengths & Weaknesses
7.11 Novogene
  7.11.1 Novogene Details
  7.11.2 Novogene Major Business
  7.11.3 Novogene Next-Generation Sequencing (NGS) Services Product and Services
  7.11.4 Novogene Next-Generation Sequencing (NGS) Services Revenue, Gross Margin and Market Share (2021-2026)
  7.11.5 Novogene Recent Developments/Updates
  7.11.6 Novogene Competitive Strengths & Weaknesses
7.12 Pacific Biosciences
  7.12.1 Pacific Biosciences Details
  7.12.2 Pacific Biosciences Major Business
  7.12.3 Pacific Biosciences Next-Generation Sequencing (NGS) Services Product and Services
  7.12.4 Pacific Biosciences Next-Generation Sequencing (NGS) Services Revenue, Gross Margin and Market Share (2021-2026)
  7.12.5 Pacific Biosciences Recent Developments/Updates
  7.12.6 Pacific Biosciences Competitive Strengths & Weaknesses
7.13 Azenta Life Sciences
  7.13.1 Azenta Life Sciences Details
  7.13.2 Azenta Life Sciences Major Business
  7.13.3 Azenta Life Sciences Next-Generation Sequencing (NGS) Services Product and Services
  7.13.4 Azenta Life Sciences Next-Generation Sequencing (NGS) Services Revenue, Gross Margin and Market Share (2021-2026)
  7.13.5 Azenta Life Sciences Recent Developments/Updates
  7.13.6 Azenta Life Sciences Competitive Strengths & Weaknesses

8 INDUSTRY CHAIN ANALYSIS

8.1 Next-Generation Sequencing (NGS) Services Industry Chain
8.2 Next-Generation Sequencing (NGS) Services Upstream Analysis
8.3 Next-Generation Sequencing (NGS) Services Midstream Analysis
8.4 Next-Generation Sequencing (NGS) Services Downstream Analysis

9 RESEARCH FINDINGS AND CONCLUSION

10 APPENDIX

10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer


LIST OF FIGURES

Table 1. World Next-Generation Sequencing (NGS) Services Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Next-Generation Sequencing (NGS) Services Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Next-Generation Sequencing (NGS) Services Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Next-Generation Sequencing (NGS) Services Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Next-Generation Sequencing (NGS) Services Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Next-Generation Sequencing (NGS) Services Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Next-Generation Sequencing (NGS) Services Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Next-Generation Sequencing (NGS) Services Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Next-Generation Sequencing (NGS) Services Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Next-Generation Sequencing (NGS) Services Players in 2025
Table 12. World Next-Generation Sequencing (NGS) Services Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Next-Generation Sequencing (NGS) Services Company Evaluation Quadrant
Table 14. Head Office of Key Next-Generation Sequencing (NGS) Services Players
Table 15. Next-Generation Sequencing (NGS) Services Market: Company Product Type Footprint
Table 16. Next-Generation Sequencing (NGS) Services Market: Company Product Application Footprint
Table 17. Next-Generation Sequencing (NGS) Services Mergers & Acquisitions Activity
Table 18. United States VS China Next-Generation Sequencing (NGS) Services Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Next-Generation Sequencing (NGS) Services Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Next-Generation Sequencing (NGS) Services Companies, Headquarters (States, Country)
Table 21. United States Based Companies Next-Generation Sequencing (NGS) Services Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Next-Generation Sequencing (NGS) Services Revenue Market Share (2021-2026)
Table 23. China Based Next-Generation Sequencing (NGS) Services Companies, Headquarters (Province, Country)
Table 24. China Based Companies Next-Generation Sequencing (NGS) Services Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Next-Generation Sequencing (NGS) Services Revenue Market Share (2021-2026)
Table 26. Rest of World Based Next-Generation Sequencing (NGS) Services Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Next-Generation Sequencing (NGS) Services Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Next-Generation Sequencing (NGS) Services Revenue Market Share (2021-2026)
Table 29. World Next-Generation Sequencing (NGS) Services Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Next-Generation Sequencing (NGS) Services Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Next-Generation Sequencing (NGS) Services Market Size by Type (2027-2032) & (USD Million)
Table 32. World Next-Generation Sequencing (NGS) Services Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 33. World Next-Generation Sequencing (NGS) Services Market Size by Application (2021-2026) & (USD Million)
Table 34. World Next-Generation Sequencing (NGS) Services Market Size by Application (2027-2032) & (USD Million)
Table 35. Eurofins Scientific Basic Information, Manufacturing Base and Competitors
Table 36. Eurofins Scientific Major Business
Table 37. Eurofins Scientific Next-Generation Sequencing (NGS) Services Product and Services
Table 38. Eurofins Scientific Next-Generation Sequencing (NGS) Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 39. Eurofins Scientific Recent Developments/Updates
Table 40. Eurofins Scientific Competitive Strengths & Weaknesses
Table 41. Natera Basic Information, Manufacturing Base and Competitors
Table 42. Natera Major Business
Table 43. Natera Next-Generation Sequencing (NGS) Services Product and Services
Table 44. Natera Next-Generation Sequencing (NGS) Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. Natera Recent Developments/Updates
Table 46. Natera Competitive Strengths & Weaknesses
Table 47. BGI Basic Information, Manufacturing Base and Competitors
Table 48. BGI Major Business
Table 49. BGI Next-Generation Sequencing (NGS) Services Product and Services
Table 50. BGI Next-Generation Sequencing (NGS) Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. BGI Recent Developments/Updates
Table 52. BGI Competitive Strengths & Weaknesses
Table 53. Illumina Basic Information, Manufacturing Base and Competitors
Table 54. Illumina Major Business
Table 55. Illumina Next-Generation Sequencing (NGS) Services Product and Services
Table 56. Illumina Next-Generation Sequencing (NGS) Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. Illumina Recent Developments/Updates
Table 58. Illumina Competitive Strengths & Weaknesses
Table 59. Roche Basic Information, Manufacturing Base and Competitors
Table 60. Roche Major Business
Table 61. Roche Next-Generation Sequencing (NGS) Services Product and Services
Table 62. Roche Next-Generation Sequencing (NGS) Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. Roche Recent Developments/Updates
Table 64. Roche Competitive Strengths & Weaknesses
Table 65. LabCorp Basic Information, Manufacturing Base and Competitors
Table 66. LabCorp Major Business
Table 67. LabCorp Next-Generation Sequencing (NGS) Services Product and Services
Table 68. LabCorp Next-Generation Sequencing (NGS) Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. LabCorp Recent Developments/Updates
Table 70. LabCorp Competitive Strengths & Weaknesses
Table 71. Berry Genomics Basic Information, Manufacturing Base and Competitors
Table 72. Berry Genomics Major Business
Table 73. Berry Genomics Next-Generation Sequencing (NGS) Services Product and Services
Table 74. Berry Genomics Next-Generation Sequencing (NGS) Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. Berry Genomics Recent Developments/Updates
Table 76. Berry Genomics Competitive Strengths & Weaknesses
Table 77. Thermo Fisher Scientific Basic Information, Manufacturing Base and Competitors
Table 78. Thermo Fisher Scientific Major Business
Table 79. Thermo Fisher Scientific Next-Generation Sequencing (NGS) Services Product and Services
Table 80. Thermo Fisher Scientific Next-Generation Sequencing (NGS) Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. Thermo Fisher Scientific Recent Developments/Updates
Table 82. Thermo Fisher Scientific Competitive Strengths & Weaknesses
Table 83. Macrogen Basic Information, Manufacturing Base and Competitors
Table 84. Macrogen Major Business
Table 85. Macrogen Next-Generation Sequencing (NGS) Services Product and Services
Table 86. Macrogen Next-Generation Sequencing (NGS) Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. Macrogen Recent Developments/Updates
Table 88. Macrogen Competitive Strengths & Weaknesses
Table 89. Oxford Nanopore Basic Information, Manufacturing Base and Competitors
Table 90. Oxford Nanopore Major Business
Table 91. Oxford Nanopore Next-Generation Sequencing (NGS) Services Product and Services
Table 92. Oxford Nanopore Next-Generation Sequencing (NGS) Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. Oxford Nanopore Recent Developments/Updates
Table 94. Oxford Nanopore Competitive Strengths & Weaknesses
Table 95. Novogene Basic Information, Manufacturing Base and Competitors
Table 96. Novogene Major Business
Table 97. Novogene Next-Generation Sequencing (NGS) Services Product and Services
Table 98. Novogene Next-Generation Sequencing (NGS) Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. Novogene Recent Developments/Updates
Table 100. Novogene Competitive Strengths & Weaknesses
Table 101. Pacific Biosciences Basic Information, Manufacturing Base and Competitors
Table 102. Pacific Biosciences Major Business
Table 103. Pacific Biosciences Next-Generation Sequencing (NGS) Services Product and Services
Table 104. Pacific Biosciences Next-Generation Sequencing (NGS) Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. Pacific Biosciences Recent Developments/Updates
Table 106. Pacific Biosciences Competitive Strengths & Weaknesses
Table 107. Azenta Life Sciences Basic Information, Manufacturing Base and Competitors
Table 108. Azenta Life Sciences Major Business
Table 109. Azenta Life Sciences Next-Generation Sequencing (NGS) Services Product and Services
Table 110. Azenta Life Sciences Next-Generation Sequencing (NGS) Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. Azenta Life Sciences Recent Developments/Updates
Table 112. Azenta Life Sciences Competitive Strengths & Weaknesses
Table 113. Global Key Players of Next-Generation Sequencing (NGS) Services Upstream (Raw Materials)
Table 114. Global Next-Generation Sequencing (NGS) Services Typical Customers

LIST OF FIGURES

Figure 1. Next-Generation Sequencing (NGS) Services Picture
Figure 2. World Next-Generation Sequencing (NGS) Services Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Next-Generation Sequencing (NGS) Services Total Revenue (2021-2032) & (USD Million)
Figure 4. World Next-Generation Sequencing (NGS) Services Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Next-Generation Sequencing (NGS) Services Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Next-Generation Sequencing (NGS) Services Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Next-Generation Sequencing (NGS) Services Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Next-Generation Sequencing (NGS) Services Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Next-Generation Sequencing (NGS) Services Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Next-Generation Sequencing (NGS) Services Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Next-Generation Sequencing (NGS) Services Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Next-Generation Sequencing (NGS) Services Revenue (2021-2032) & (USD Million)
Figure 13. Next-Generation Sequencing (NGS) Services Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Next-Generation Sequencing (NGS) Services Consumption Value (2021-2032) & (USD Million)
Figure 16. World Next-Generation Sequencing (NGS) Services Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Next-Generation Sequencing (NGS) Services Consumption Value (2021-2032) & (USD Million)
Figure 18. China Next-Generation Sequencing (NGS) Services Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Next-Generation Sequencing (NGS) Services Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Next-Generation Sequencing (NGS) Services Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Next-Generation Sequencing (NGS) Services Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Next-Generation Sequencing (NGS) Services Consumption Value (2021-2032) & (USD Million)
Figure 23. India Next-Generation Sequencing (NGS) Services Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Next-Generation Sequencing (NGS) Services by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Next-Generation Sequencing (NGS) Services Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Next-Generation Sequencing (NGS) Services Markets in 2025
Figure 27. United States VS China: Next-Generation Sequencing (NGS) Services Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Next-Generation Sequencing (NGS) Services Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Next-Generation Sequencing (NGS) Services Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Next-Generation Sequencing (NGS) Services Market Size Market Share by Type in 2025
Figure 31. Targeted Sequencing
Figure 32. Whole Exome Sequencing
Figure 33. Whole Genome Sequencing
Figure 34. World Next-Generation Sequencing (NGS) Services Market Size Market Share by Type (2021-2032)
Figure 35. World Next-Generation Sequencing (NGS) Services Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 36. World Next-Generation Sequencing (NGS) Services Market Size Market Share by Application in 2025
Figure 37. Hospitals and Clinics
Figure 38. Biopharma Companies
Figure 39. Academic & Research Organizations
Figure 40. Others
Figure 41. World Next-Generation Sequencing (NGS) Services Market Size Market Share by Application (2021-2032)
Figure 42. Next-Generation Sequencing (NGS) Services Industrial Chain
Figure 43. Methodology
Figure 44. Research Process and Data Source


More Publications